NCT00305435View on ClinicalTrials.gov

Safety Study of AMG 531 in Japanese Subjects With ITP

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions
DRUG

Romiplostim (AMG-531)

Romiplostim (AMG-531)

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT00305435 - Safety Study of AMG 531 in Japanese Subjects With ITP | Biotech Hunter | Biotech Hunter